Native Valve Endocarditis and Pacemaker Infection with Mycobacterium Fortuitum: A Descriptive Approach| Chapter 11 | Current Overview on Disease and Health Vol. 7

 We characterize a case of native tricuspid valve endocarditis and pacemaker contamination secondary to M. fortuitum. We likewise review the published literature on cardiac ploy–associated infections and native faucet endocarditis caused by M. fortuitum. Endocarditis and cardiac device contamination due to Mycobacterium fortuitum is a exceptional entities in hospital backgrounds. Most endocarditis has an infectious cause of bacterial origin. Being a affliction of the endocardium, it not only affects native constructions -more frequently the valves or cardiac structures endanger special hemodynamic environments such as in congenital heart disease-, but still other endothelizable surfaces, in the way that valve prostheses, catheters, electrodes, or percutaneous devices. Two days afterwards admission, with turmoil, chills, body aches, and lump around her pacemaker, the patient’s troting system was surgically detached. The patient was discharged on day 16 later surgery and discussed with a multidrug regimen of azithromycin, levofloxacin, imipenem/ cilastatin, and amikacin for six weeks, trailed by trimethoprim/ sulfamethoxazole plus doxycycline for a further three months.

Author(s) Details:

Moamen Al Zoubi,
Department of Internal Medicine, University of Illinois College of Medicine, Rockford, Illinois, USA and Department of Infectious Disease, Mercyhealth, Rockford, Illinois, USA.

Please see the link here: https://stm.bookpi.org/CODH-V7/article/view/9085

Mechanisms of Antimicrobial Resistance in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)| Chapter 9 | Challenges and Advances in Pharmaceutical Research Vol. 6

 In the medical field, antibiotics are frequently used to treat a variety of infectious disorders. High death rates, rising healthcare costs, and decreasing productivity have all been linked to antimicrobial resistance. The chapter sought to highlight the most recent mechanisms and causes of antibiotic resistance in soronavirus-2, which causes severe acute respiratory syndrome (SARS-CoV-2). The development of antibiotic-resistant bacteria is largely caused by the abuse of antibiotics and other socioeconomic factors.  Investigations found that despite the fact that only 10% to 15% of infected SARS-CoV-2 cases had secondary bacterial infection, healthcare systems are treating all SARS-CoV-2 infections with antibiotics, even when the symptoms are moderate. The evolution of antibiotic resistance is also being exacerbated by overworked healthcare systems, inadequate infection control procedures, and increased production of personal protective equipment (PPE). Emerging COVID-19 genetic variations have been shown to reduce the effectiveness of many COVID-19 vaccinations, demonstrating the necessity of routine booster shots. In healthcare settings, antibiotic stewardship should be encouraged with the appropriate flexibility as necessary.

Author(s) Details:

Mohamed Raslan,
Drug Research Centre, Cairo, Egypt.

M. S. Eslam,
Drug Research Centre, Cairo, Egypt.

A. R. Sara,
Drug Research Centre, Cairo, Egypt.

Nagwa A. Sabri,
Department of Clinical Pharmacy, Faculty of Pharmacy- Ain Shams University, Cairo, Egypt.

Please see the link here: https://stm.bookpi.org/CAPR-V6/article/view/8097

Gas Chromatographic–Mass Spectrometric Determination of Azithromycin in Biological Fluids: An Experimental Investigation| Chapter 15 | New Innovations in Chemistry and Biochemistry Vol.7

 Antibiotics are now commonly utilised in food-producing animals to stimulate growth and preserve optimal health. The antibiotic azithromycin monohydrate belongs to the macrolide antibiotic class. As an efficient antibiotic, it is used to treat sexually transmitted illnesses, upper and lower respiratory tract infections, and skin structure infections.

Methods: A method for determining azithromycin monohydrate residue in bodily fluids using a gas chromatographic–mass spectrometric (GC–MS) method is described. This approach identifies residual azithromycin (AZM) in biological fluids using single-ion monitoring (SIM). If the residual level in a sample is greater than 5 g/mL, a full-scan electron impact (EI) mass spectrum can be used to corroborate the results. Before partitioning between chloroform and phosphate buffer solution, AZM is extracted from a sample with chloroform and cleaned up with n-hexane washing. The cleaned extract is acetylated in an acetic anhydride–pyridine combination at room temperature (1:2).
Results: The reaction mixture was put into the GC–MS instrument, and SIM at m/z 200 was used to detect it. 2 g/mL is the detection limit.
Conclusions: This proposed method has the potential to be used in both forensic and toxicological laboratories to analyse drugs.

Author(s) Details:

Subbiah Thangadurai,
Post Graduate Studies and Research Department of Chemistry, Raja Doraisingam Government Arts College, Government of Tamil Nadu, 630 561 Sivagangai, India.

Please see the link here: https://stm.bookpi.org/NICB-V7/article/view/5978